Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bovine ephemeral fever virus (BEFV) is an arthropod-borne rhabdovirus that serves as the causative agent of bovine ephemeral fever, commonly known as three-day sickness, in cattle and water buffalo. The virus is characterized by a single-stranded, negative-sense RNA genome encoding five structural proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), large RNA-dependent RNA polymerase (L), and a surface glycoprotein (G) which is the primary target for neutralizing antibodies. BEFV is transmitted by hematophagous insects such as mosquitoes and biting midges, leading to clinical symptoms including sudden high fever, lameness, and a significant decrease in milk yield. While there are no specific antiviral drugs for BEFV, management typically involves the use of anti-inflammatory agents to alleviate symptoms and the administration of vaccines to provide protective immunity. The virus is considered a significant veterinary pathogen due to its substantial economic impact on the livestock industry in tropical and subtropical regions.
Vaccines induce neutralizing antibodies primarily against the viral G glycoprotein to prevent infection; non-steroidal anti-inflammatory drugs (NSAIDs) are used symptomatically to reduce fever and inflammation associated with the disease.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bovine ephemeral fever virus (BEFV).